Search Results

Fenofibric Acid: In Combination Therapy in the Treatment of Mixed Dyslipidemia

Authors: Yang, Lily P.H.; Keating, Gillian M.

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 6, 1 December 2009 , pp. 401-409(9)

Publisher: Adis International

Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?

Author: Drexel, Heinz

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 6, December 2009 , pp. 687-692(6)

Publisher: Blackwell Publishing

Dyslipidemia as a Risk Factor for Ischemic Stroke

Authors: Tziomalos, Konstantinos; Athyros, Vasilios G.; Karagiannis, Asterios; Mikhailidis, Dimitri P.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 14, October 2009 , pp. 1291-1297(7)

Publisher: Bentham Science Publishers

The Role of Polyunsaturated Fatty Acids (PUFA) in the Treatment of Dyslipidemias

Authors: Zuliani, G.; Galvani, M.; Leitersdorf, E.; Volpato, S.; Cavalieri, M.; Fellin, R.

Source: Current Pharmaceutical Design, Volume 15, Number 36, December 2009 , pp. 4087-4093(7)

Publisher: Bentham Science Publishers

Gene-Activators Prevent and Regress Atherosclerosis and Reduce Mortality

Author: Luoma, Pauli V.

Source: Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Volume 7, Number 4, October 2009 , pp. 295-304(10)

Publisher: Bentham Science Publishers

Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies

Authors: Panadero, M. I.; Gonzalez, M. C.; Herrera, E.; Bocos, C.

Source: Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru, Volume 9, Number 3, September 2009 , pp. 219-236(18)

Publisher: Bentham Science Publishers

Anti-Atherosclerotic Molecules Targeting Oxidative Stress and Inflammation

Authors: Adameova, A.; Xu, Y. J.; Duhamel, T. A.; Tappia, P. S.; Shan, L.; Dhalla, N. S.

Source: Current Pharmaceutical Design, Volume 15, Number 27, September 2009 , pp. 3094-3107(14)

Publisher: Bentham Science Publishers

Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

Authors: Florentin, M.; Elisaf, M. S.; Mikhailidis, D. P.; Liberopoulos, E. N.

Source: Current Pharmaceutical Design, Volume 15, Number 29, October 2009 , pp. 3446-3462(17)

Publisher: Bentham Science Publishers

Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity

Authors: Camps, Jordi; Marsillach; Joven, Jorge

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 8, July 2009 , pp. 911-920(10)

Publisher: Bentham Science Publishers

Nuclear receptors as therapeutic targets in cholestatic liver diseases

Authors: Zollner, Gernot; Trauner, Michael

Source: British Journal of Pharmacology, Volume 156, Number 1, January 2009 , pp. 7-27(21)

Publisher: Blackwell Publishing

Statins and Erectile Dysfunction: Results of a Case/Non-Case Study using the French Pharmacovigilance System Database

Authors: Do, Catherine; Huyghe, Eric; Lapeyre-Mestre, Maryse; >Jean Louis Montastruc,; Bagheri, Haleh

Source: Drug Safety, Volume 32, Number 7, 1 July 2009 , pp. 591-597(7)

Publisher: Adis International

Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work

Author: Fedson, David S.

Source: Influenza and Other Respiratory Viruses, Volume 3, Number 4, July 2009 , pp. 129-142(14)

Publisher: Blackwell Publishing

Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol

Authors: Toth, Peter P.; Zarotsky, Victoria; Sullivan, Jane M.; Laitinen, Dave

Source: Current Medical Research and Opinion, Volume 25, Number 6, June 2009 , pp. 1355-1363(9)

Publisher: Informa Healthcare

Fibrates in the Chemical Action of Daunorubicin

Author: Balendiran, Ganesaratnam K.

Source: Current Cancer Drug Targets, Volume 9, Number 3, May 2009 , pp. 366-369(4)

Publisher: Bentham Science Publishers

Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence

Authors: Preiss, David; Sattar, Naveed

Source: Clinical Endocrinology, Volume 70, Number 6, June 2009 , pp. 815-828(14)

Publisher: Blackwell Publishing

Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies

Authors: Tziomalos, Konstantinos; Athyros, Vasilios G.; Karagiannis, Asterios; Kolovou, Genovefa D.; Mikhailidis, Dimitri P.

Source: Current Drug Targets, Volume 10, Number 4, April 2009 , pp. 320-327(8)

Publisher: Bentham Science Publishers

Potential Options to Treat Hypertriglyceridaemia

Authors: Viljoen, Adie; Wierzbicki, Anthony S.

Source: Current Drug Targets, Volume 10, Number 4, April 2009 , pp. 356-362(7)

Publisher: Bentham Science Publishers

Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression

Authors: Pierno, S; Camerino, GM; Cippone, V; Rolland, J-F; Desaphy, J-F; De Luca, A; Liantonio, A; Bianco, G; Kunic, JD; George Jr., AL; Conte Camerino, D

Source: British Journal of Pharmacology, Volume 156, Number 8, April 2009 , pp. 1206-1215(10)

Publisher: Blackwell Publishing

Anti-Inflammatory Effects of Fibrates: An Overview

Authors: Tziomalos, Konstantinos; Athyros, Vasilios G.; Karagiannis, Asterios; Mikhailidis, Dimitri P.

Source: Current Medicinal Chemistry, Volume 16, Number 6, February 2009 , pp. 676-684(9)

Publisher: Bentham Science Publishers

Interpreting clinical trials of diabetic dyslipidaemia: new insights

Author: Wierzbicki

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 3, March 2009 , pp. 261-270(10)

Publisher: Blackwell Publishing